Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology
F
Biotech is Zen Rated F and is the 141st ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Price
1d %
1w %
1m %
3m %
6m %
1y %
3y %
5y %
10y %
52-week High
52-week Low
% off 52-week High
% off 52-week Low
Beta
Volume
Vol 1d %
LYRA
LYRA THERAPEUTICS INC
$6.97-3.99%-16.92%-22.21%17.34%-23.87%-56.40%-97.86%-98.97%N/A$37.50$3.8181.41%82.94%0.5862,000103.28%
MGNX
MACROGENICS INC
$1.54-2.53%-14.92%27.27%-11.24%-48.84%-70.67%-50.64%-94.24%-95.86%$5.10$0.9969.80%55.56%1.451,454,000299.45%
APGE
APOGEE THERAPEUTICS INC
$37.61-0.84%-7.32%-13.40%-4.18%-11.51%-21.48%N/AN/AN/A$63.50$26.2040.77%43.55%1.29701,000-10.24%
SGMT
SAGIMET BIOSCIENCES INC
$8.89-4.10%-7.30%16.67%157.68%118.97%150.42%N/AN/AN/A$11.41$1.7322.09%413.87%2.09573,000-17.44%
ONCO
ONCONETIX INC
$3.21-11.33%-14.17%-32.70%-48.34%-93.31%-99.43%-99.96%N/AN/A$656.88$3.0999.51%3.88%0.75232,00069.34%
ELTX
ELICIO THERAPEUTICS INC
$9.93-1.73%1.17%28.56%101.73%5.36%98.90%-7.24%N/AN/A$10.75$3.707.67%168.24%1.0476,000190.08%
IMTX
IMMATICS NV
$6.680.75%3.57%24.16%33.60%23.70%-43.77%-41.20%-39.82%N/A$13.09$3.3048.97%102.42%0.93372,000-29.68%
VRDN
VIRIDIAN THERAPEUTICS INC
$17.806.02%-0.84%27.32%31.37%-11.35%6.59%31.08%8.87%-95.17%$27.20$9.9034.56%79.80%0.601,140,000184.29%
INAB
IN8BIO INC
$2.15-2.27%-12.60%2.87%-57.59%-71.09%-91.35%-96.99%N/AN/A$25.50$2.0591.57%4.88%0.96123,000-22.64%
QSI
QUANTUM-SI INC
$1.62-0.92%-13.83%-17.35%42.11%-17.35%55.77%-49.53%N/AN/A$5.77$0.6171.92%164.71%1.914,291,000-53.46%
CRVO
CERVOMED INC
$8.500.95%3.03%35.24%-6.18%277.78%-38.80%-12.95%-90.48%-99.95%$20.63$1.8058.80%372.22%0.89297,000-50.50%
MBX
MBX BIOSCIENCES INC
$15.493.54%13.23%35.76%47.66%33.08%N/AN/AN/AN/A$27.50$4.8143.67%222.24%1.51732,00077.24%
ALT
ALTIMMUNE INC
$3.65-4.70%-14.92%-5.68%-30.48%-47.86%-42.25%-69.83%-85.99%-99.28%$11.16$2.9067.29%25.86%1.313,318,000-11.97%
ANRO
ALTO NEUROSCIENCE INC
$3.070.66%0.00%39.55%23.29%-31.17%-77.64%N/AN/AN/A$15.04$1.6079.59%91.88%0.80102,000-3.77%
CRSP
CRISPR THERAPEUTICS AG
$57.68-2.27%-15.35%18.59%49.16%37.20%2.25%-22.06%-33.21%N/A$71.13$30.0418.91%92.01%1.513,274,000-22.03%
MAZE
MAZE THERAPEUTICS INC
$15.50-1.52%-12.13%26.32%67.57%-2.82%N/AN/AN/AN/A$19.19$6.7119.23%131.00%0.77115,000-2.54%
ARTV
ARTIVA BIOTHERAPEUTICS INC
$2.982.41%-7.17%97.35%24.69%-44.81%-74.46%N/AN/AN/A$17.31$1.4782.78%102.72%1.32206,00033.77%
ALEC
ALECTOR INC
$1.60-0.62%-10.11%14.29%33.33%-6.98%-74.44%-84.27%-90.46%N/A$6.37$0.8774.88%83.91%1.57657,0004.62%
NNVC
NANOVIRICIDES INC
$1.68-1.18%-4.00%20.00%22.63%57.01%-17.24%-6.67%-72.68%-94.40%$2.34$0.9428.21%78.72%0.81331,00043.29%
ALLO
ALLOGENE THERAPEUTICS INC
$1.29-7.86%-22.29%14.16%-23.21%-32.81%-56.57%-89.36%-96.62%N/A$3.78$0.8665.87%49.65%1.419,255,000363.91%
PCVX
VAXCYTE INC
$34.820.40%-4.50%7.11%-2.85%-62.13%-56.42%52.52%8.88%N/A$121.06$27.6671.24%25.89%0.82990,000-8.92%
MRNA
MODERNA INC
$32.15-1.56%-7.27%16.53%12.65%-21.66%-72.95%-80.09%-58.59%N/A$102.90$23.1568.76%38.88%1.256,069,000-26.61%
OMER
OMEROS CORP
$3.85-3.02%0.79%28.33%-47.62%-56.45%-26.25%-14.44%-71.79%-76.18%$13.60$2.9571.69%30.51%1.451,405,000-18.03%
ETNB
89BIO INC
$9.533.36%-5.46%-2.95%18.83%-1.14%4.84%170.74%-67.24%N/A$11.84$4.1619.51%129.09%1.021,245,000-43.77%
ROIV
ROIVANT SCIENCES LTD
$11.40-0.18%0.09%1.15%-1.89%0.26%6.84%209.78%N/AN/A$13.06$8.7312.68%30.58%0.843,400,000-10.67%
AARD
AARDVARK THERAPEUTICS INC
$12.69-2.23%-10.82%-6.14%14.22%N/AN/AN/AN/AN/A$19.58$4.8835.19%160.04%1.3526,000-7.14%
DBVT
DBV TECHNOLOGIES SA
$9.40-4.12%-0.76%2.58%4.28%120.56%98.40%-62.57%-75.59%-97.81%$12.78$2.2026.48%326.32%0.5148,700-72.01%
IRON
DISC MEDICINE INC
$59.35-0.75%-2.61%12.07%20.09%6.74%37.93%273.27%N/AN/A$68.73$30.8213.65%92.57%0.84377,00091.37%
NUVL
NUVALENT INC
$79.540.42%-1.17%4.25%3.64%-9.36%2.11%452.36%N/AN/A$113.51$55.5429.93%43.22%1.51302,000-34.63%
SYRE
SPYRE THERAPEUTICS INC
$17.293.10%-2.92%15.50%13.53%-22.36%-39.80%77.30%-90.08%N/A$40.26$10.9157.05%58.48%1.06870,000209.61%
TIL
INSTIL BIO INC
$27.01-4.46%-8.97%29.67%110.19%12.49%118.70%-73.73%N/AN/A$92.00$9.8570.64%174.21%1.77131,000-19.63%
JANX
JANUX THERAPEUTICS INC
$24.230.25%-8.43%4.89%-27.02%-45.90%-41.23%109.78%N/AN/A$71.71$22.4866.21%7.78%1.52595,000-17.13%
MBRX
MOLECULIN BIOTECH INC
$0.71-0.42%0.28%135.43%-32.92%-53.83%-77.50%-97.16%-99.29%N/A$3.65$0.2580.52%184.40%0.855,228,000-70.84%
OABI
OMNIAB INC
$1.95-0.51%-9.30%12.07%14.71%-39.25%-59.21%-80.73%-81.18%N/A$4.87$1.2259.96%59.84%0.57558,000-7.92%
CRVS
CORVUS PHARMACEUTICALS INC
$4.38-3.10%-6.21%9.50%22.01%-17.20%65.91%396.60%2.58%N/A$10.00$2.4756.20%77.33%1.07403,00049.81%
ACLX
ARCELLX INC
$71.542.21%2.24%8.64%10.15%5.86%16.00%224.59%N/AN/A$107.37$47.8633.37%49.48%1.03761,00088.83%
CGEM
CULLINAN THERAPEUTICS INC
$8.16-2.16%-2.04%8.37%-1.45%-25.68%-57.17%-38.65%N/AN/A$19.89$6.8558.97%19.12%1.271,166,000289.97%
SILO
SILO PHARMA INC
$0.690.14%-0.29%9.84%-7.73%-62.19%-67.51%N/AN/AN/A$3.37$0.4179.47%68.78%0.65603,000-78.64%
ABOS
ACUMEN PHARMACEUTICALS INC
$1.465.80%-13.10%25.86%29.20%-6.41%-57.31%-70.80%N/AN/A$3.36$0.8656.55%70.76%1.39622,000157.02%
CRNX
CRINETICS PHARMACEUTICALS INC
$29.23-0.14%-5.65%1.63%-12.46%-27.40%-44.47%60.69%99.66%N/A$62.53$24.1053.25%21.29%1.26892,000-5.71%
APLS
APELLIS PHARMACEUTICALS INC
$19.000.26%-4.52%9.76%-1.09%-37.48%-51.57%-65.93%-31.95%N/A$41.94$16.1054.70%18.01%1.023,857,000-29.96%
MLYS
MINERALYS THERAPEUTICS INC
$14.494.39%8.87%7.10%1.97%41.09%15.92%N/AN/AN/A$18.38$8.2421.16%75.83%1.01666,0007.42%
ONCY
ONCOLYTICS BIOTECH INC
$1.041.96%-12.61%34.54%82.14%42.08%-0.95%-10.34%-49.27%N/A$1.53$0.3332.03%219.02%0.87694,000-70.57%
THRD
THIRD HARMONIC BIO INC
$5.38-0.09%-0.92%-0.92%4.06%0.56%-56.82%N/AN/AN/A$16.02$3.1866.42%69.18%0.751,418,000345.91%
FDMT
4D MOLECULAR THERAPEUTICS INC
$4.411.15%-6.37%18.87%30.86%-21.25%-74.30%-51.05%N/AN/A$18.02$2.2475.53%97.32%1.33322,0008.42%
APVO
APTEVO THERAPEUTICS INC
$2.922.10%-9.88%-4.26%-72.45%-96.73%-99.01%-100.00%-100.00%N/A$381.10$2.8199.23%3.91%1.2024,700-78.14%
OSTX
OS THERAPIES INC
$1.75-4.37%-4.37%-6.91%-13.79%-10.26%-30.28%N/AN/AN/A$7.00$1.1275.00%56.25%0.76177,000-47.48%
COGT
COGENT BIOSCIENCES INC
$11.53-2.62%-6.79%60.58%121.31%19.85%21.37%11.83%8.77%N/A$12.97$3.7211.10%209.95%0.981,934,00070.55%
KYTX
KYVERNA THERAPEUTICS INC
$3.76-2.34%-13.16%22.48%62.77%13.60%-57.03%N/AN/AN/A$8.84$1.7857.47%111.24%1.45138,000-48.12%
TARA
PROTARA THERAPEUTICS INC
$3.18-4.50%-6.19%4.95%-9.14%-29.33%43.89%1.60%-87.66%-99.53%$10.48$1.6069.66%99.37%1.11358,00070.48%
AUTL
AUTOLUS THERAPEUTICS PLC
$2.492.89%-7.09%9.21%76.60%13.18%-44.30%-6.39%-81.16%N/A$5.00$1.1150.20%125.34%1.022,113,0002.27%
ELVN
ENLIVEN THERAPEUTICS INC
$19.32-3.74%-13.56%-3.69%2.01%-9.17%-26.06%305.88%-76.12%N/A$30.03$13.3035.66%45.26%1.03304,00024.59%
MGX
METAGENOMI INC
$2.27-3.40%-4.62%53.38%31.21%-20.35%-43.25%N/AN/AN/A$4.92$1.2353.86%84.55%0.80413,000-49.82%
ARDX
ARDELYX INC
$4.342.84%-1.14%10.71%-21.16%-19.03%-21.38%551.65%-24.78%-77.01%$7.18$3.2139.55%35.20%1.144,006,00058.47%
NTLA
INTELLIA THERAPEUTICS INC
$12.33-1.36%-13.41%31.45%39.01%17.32%-53.06%-80.35%-34.10%N/A$26.63$5.9053.70%108.98%1.994,439,000-9.46%
GUTS
FRACTYL HEALTH INC
$1.820.00%-5.21%12.35%43.31%-6.19%-54.61%N/AN/AN/A$3.72$0.8751.08%108.48%0.99140,000-28.21%
BTAI
BIOXCEL THERAPEUTICS INC
$1.43-10.06%-20.99%-20.99%-22.70%-72.32%-91.80%-99.35%-99.82%N/A$18.08$1.1792.09%22.22%1.59390,00037.32%
PRME
PRIME MEDICINE INC
$3.922.35%-15.52%58.70%126.59%38.52%-27.81%N/AN/AN/A$5.62$1.1130.25%253.15%1.912,376,000-46.28%
ANNX
ANNEXON INC
$2.598.82%4.44%7.92%39.25%-35.89%-58.29%-42.70%-85.93%N/A$7.85$1.2967.01%101.56%1.031,572,000149.13%
CAPR
CAPRICOR THERAPEUTICS INC
$8.1821.36%19.94%-17.62%-35.59%-46.18%100.49%86.33%8.49%-81.15%$23.40$3.5265.04%132.39%1.026,035,000204.34%
VIR
VIR BIOTECHNOLOGY INC
$5.24-0.19%-10.43%3.97%-14.38%-49.18%-48.32%-80.90%-88.87%N/A$14.45$4.3263.74%21.30%1.23902,00032.45%
NKTX
NKARTA INC
$2.185.83%-2.24%31.33%2.83%-7.63%-65.67%-82.50%-91.99%N/A$6.66$1.3167.27%66.41%1.46790,000100.51%
TNYA
TENAYA THERAPEUTICS INC
$0.734.26%-15.54%20.13%54.53%-30.75%-80.27%-83.58%N/AN/A$4.01$0.3681.70%103.89%1.833,061,00011.63%
TELO
TELOMIR PHARMACEUTICALS INC
$1.96-4.39%-4.85%56.80%-23.14%-56.64%-48.56%N/AN/AN/A$8.40$1.1276.67%75.00%0.971,077,00056.77%
VYGR
VOYAGER THERAPEUTICS INC
$3.468.13%5.49%11.25%-2.81%-38.32%-62.63%-46.19%-69.78%N/A$9.21$2.6562.43%30.57%1.301,839,000253.65%
GRI
GRI BIO INC
$2.054.59%0.49%58.91%12.64%-81.64%-84.70%-99.99%N/AN/A$30.43$1.1093.26%86.36%0.85206,0001.98%
CLDI
CALIDI BIOTHERAPEUTICS INC
$0.59-7.44%-20.84%154.35%21.37%-6.55%-63.44%-99.41%N/AN/A$3.89$0.2184.96%185.37%0.445,146,000-97.11%
PTIX
PROTAGENIC THERAPEUTICS INC
$3.193.91%-5.34%-12.60%1.72%-40.35%-67.45%-90.51%-95.13%-99.26%$15.54$2.3579.47%35.74%-0.13218,000227.33%
BEAM
BEAM THERAPEUTICS INC
$20.151.10%-9.07%18.46%1.10%-26.14%-36.23%-65.75%-1.08%N/A$35.25$13.5342.84%48.98%2.032,781,00046.83%
OTLK
OUTLOOK THERAPEUTICS INC
$2.054.06%-1.44%28.13%30.57%1.49%-73.06%-90.93%-92.57%N/A$8.32$0.8775.36%135.63%1.111,272,000158.01%
MDCX
MEDICUS PHARMA LTD
$2.50-3.47%-18.03%-16.39%-40.53%-8.09%N/AN/AN/AN/A$8.94$1.8072.04%38.89%0.72285,000-12.84%
OVID
OVID THERAPEUTICS INC
$0.50-7.41%-28.57%51.52%52.91%-28.57%-52.15%-75.96%-92.42%N/A$1.47$0.2465.99%106.61%0.891,167,0006.97%
BLRX
BIOLINERX LTD
$4.01-2.91%-12.06%-12.25%15.56%12.32%-86.83%-92.68%-95.36%-99.57%$35.02$2.3088.55%74.35%0.8249,000113.04%
RCKT
ROCKET PHARMACEUTICALS INC
$3.144.32%-6.55%28.16%-58.85%-70.63%-87.21%-77.15%-87.21%-94.14%$24.27$2.1987.06%43.38%1.603,972,000147.48%
CLDX
CELLDEX THERAPEUTICS INC
$22.813.92%-4.44%12.09%9.51%-9.70%-40.66%-22.83%119.12%-93.53%$47.00$14.4051.47%58.40%1.241,020,00047.19%
GLSI
GREENWICH LIFESCIENCES INC
$11.251.08%-2.09%24.04%11.39%-14.71%-28.75%44.05%N/AN/A$16.50$8.0631.82%39.58%0.5748,500210.90%
KLTO
KLOTHO NEUROSCIENCES INC
$0.993.23%-21.97%-12.30%500.61%150.25%-27.13%-89.97%N/AN/A$3.91$0.1174.65%769.30%0.581,849,000-46.56%
DMAC
DIAMEDICA THERAPEUTICS INC
$4.45-3.05%-13.59%14.10%7.23%-23.93%23.27%187.10%-24.58%N/A$6.82$3.1934.73%39.50%0.80382,000-46.87%
SNTI
SENTI BIOSCIENCES INC
$1.800.00%-12.20%-14.69%-45.78%-59.28%-23.08%-93.66%N/AN/A$16.94$1.5289.37%18.42%1.2772,000-41.46%
PRQR
PROQR THERAPEUTICS NV
$2.13-2.74%-1.84%4.41%28.31%-0.93%14.52%157.25%-59.74%-86.48%$4.62$1.0753.90%99.07%0.98332,00080.43%
ABCL
ABCELLERA BIOLOGICS INC
$4.57-2.56%-8.42%33.24%75.10%41.49%41.49%-54.95%N/AN/A$5.82$1.8921.48%141.67%1.263,827,000-38.41%
SLDB
SOLID BIOSCIENCES INC
$7.070.00%4.59%45.17%113.60%112.95%-22.90%-31.10%-81.87%N/A$10.37$2.4131.82%193.36%1.271,653,0004.42%
LGVN
LONGEVERON INC
$1.581.28%-9.20%21.54%-5.95%-1.25%-51.68%-97.41%N/AN/A$3.26$1.1451.53%38.60%1.23105,000-43.85%
ALXO
ALX ONCOLOGY HOLDINGS INC
$0.602.93%17.98%43.86%10.56%-54.25%-89.05%-93.66%-98.16%N/A$3.49$0.4082.89%47.77%1.28575,000-53.48%
AURA
AURA BIOSCIENCES INC
$6.59-2.95%-5.86%5.27%13.04%-16.90%-34.36%-50.64%N/AN/A$12.38$4.3546.76%51.67%1.07241,00015.87%
CLYM
CLIMB BIO INC
$1.520.66%2.70%22.58%13.43%-21.24%-81.33%-50.00%N/AN/A$8.79$1.0582.71%44.76%0.7299,000-60.24%
VSTM
VERASTEM INC
$6.23-0.95%16.45%50.12%-16.82%0.16%133.33%-51.93%-61.54%-92.70%$9.10$2.1031.54%196.67%1.573,781,00034.36%
BCAX
BICARA THERAPEUTICS INC
$11.600.96%-1.61%24.87%-19.28%-10.15%N/AN/AN/AN/A$28.09$7.8058.70%48.72%1.61268,00012.61%
OBIO
ORCHESTRA BIOMED HOLDINGS INC
$3.12-1.27%-2.19%16.42%5.05%-44.19%-55.43%-68.58%N/AN/A$7.35$2.3757.55%31.65%0.77106,000-54.11%
IOVA
IOVANCE BIOTHERAPEUTICS INC
$2.67-8.56%-32.75%55.23%-25.63%-57.00%-70.20%-75.99%-90.75%-67.28%$12.51$1.6478.65%62.90%1.4918,985,00021.68%
ANVS
ANNOVIS BIO INC
$2.732.63%2.63%25.81%83.22%-44.17%-71.11%-75.86%-52.44%N/A$10.54$1.1174.10%145.95%1.42236,000-47.67%
KOD
KODIAK SCIENCES INC
$7.30-6.41%5.80%95.71%67.43%7.35%153.47%-23.56%-84.63%N/A$11.60$1.9237.07%280.21%1.87602,000-2.75%
XFOR
X4 PHARMACEUTICALS INC
$1.77-8.05%18.00%-6.84%-58.93%-91.09%-92.98%-95.46%-99.24%N/A$26.83$1.3893.40%28.26%1.19841,000-46.30%
VOR
VOR BIOPHARMA INC
$2.21-5.96%5.74%36.42%225.48%58.99%139.18%-54.62%N/AN/A$3.29$0.1332.83%1,587.02%1.273,650,000-43.98%
ACET
ADICET BIO INC
$0.700.14%-13.73%15.41%6.34%-20.90%-54.58%-95.73%-96.30%N/A$1.64$0.4557.07%57.49%1.24357,000-64.69%
CELC
CELCUITY INC
$40.304.68%186.83%201.87%261.76%243.86%124.39%363.75%663.26%N/A$46.42$7.5813.18%432.01%0.796,188,000-0.40%
PHAT
PHATHOM PHARMACEUTICALS INC
$8.711.04%1.63%-9.18%103.03%37.38%-24.59%-3.97%-73.52%N/A$19.71$2.2155.81%294.12%1.42890,0007.88%
ABVX
ABIVAX SA
$70.841.48%3.26%825.95%894.87%1,100.59%498.77%N/AN/AN/A$72.90$4.772.83%1,385.01%1.851,379,000-40.99%
CGTX
COGNITION THERAPEUTICS INC
$0.62-7.16%-22.73%100.65%45.67%-19.01%-43.45%-70.66%N/AN/A$1.29$0.2251.78%180.18%1.172,482,000-68.84%
PHVS
PHARVARIS NV
$19.790.92%-5.04%12.44%7.09%11.62%15.87%-1.05%N/AN/A$26.33$11.5124.84%71.94%0.48110,000134.04%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jul 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 49, which is 26 points higher than the biotech industry average of 23.

PBYI passed 16 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock lose -12.71% over the past year, overperforming other biotech stocks by 55 percentage points.

Puma Biotechnology has an average 1 year price target of $7.00, an upside of 121.52% from Puma Biotechnology's current stock price of $3.16.

Puma Biotechnology stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Ptc Therapeutics (NASDAQ:PTCT)


Ptc Therapeutics (NASDAQ:PTCT) is the #2 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ptc Therapeutics (NASDAQ:PTCT) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Ptc Therapeutics (NASDAQ:PTCT) has a Due Diligence Score of 35, which is 12 points higher than the biotech industry average of 23.

PTCT passed 11 out of 33 due diligence checks and has average fundamentals. Ptc Therapeutics has seen its stock return 54.22% over the past year, overperforming other biotech stocks by 122 percentage points.

Ptc Therapeutics has an average 1 year price target of $69.62, an upside of 36.66% from Ptc Therapeutics's current stock price of $50.94.

Ptc Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Ptc Therapeutics, 53.85% have issued a Strong Buy rating, 15.38% have issued a Buy, 23.08% have issued a hold, while 0% have issued a Sell rating, and 7.69% have issued a Strong Sell.

3. Rigel Pharmaceuticals (NASDAQ:RIGL)


Rigel Pharmaceuticals (NASDAQ:RIGL) is the #3 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 35, which is 12 points higher than the biotech industry average of 23.

RIGL passed 11 out of 33 due diligence checks and has average fundamentals. Rigel Pharmaceuticals has seen its stock return 97.46% over the past year, overperforming other biotech stocks by 165 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $39.75, an upside of 89.2% from Rigel Pharmaceuticals's current stock price of $21.01.

Rigel Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Rigel Pharmaceuticals, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)


Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 7.26%, which is 5 percentage points higher than the biotech industry average of 1.87%.

Dominari Holdings's dividend payout ratio of -7.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)


Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 3.22%, which is 1 percentage points higher than the biotech industry average of 1.87%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.2% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.75%, which is the same as the biotech industry average of 1.87%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 34.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.35% in the last day, and down -2.52% over the last week. Vyne Therapeutics was the among the top losers in the biotechnology industry, dropping -72.36% yesterday.

VYNE Therapeutics shares are trading lower after the company announced its Phase 2b trial Repibresib Gel in nonsegmental vitiligo did not meet its primary endpoint.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -12.71% in the past year. It has overperformed other stocks in the biotech industry by 55 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 4.75% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

3. United Therapeutics (NASDAQ:UTHR)


United Therapeutics (NASDAQ:UTHR) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

United Therapeutics has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

United Therapeutics's stock has dropped -16.47% in the past year. It has overperformed other stocks in the biotech industry by 51 percentage points.

Are biotech stocks a good buy now?

53.23% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 101.38% over the next year.

2.11% of biotech stocks have a Zen Rating of A (Strong Buy), 4.23% of biotech stocks are rated B (Buy), 37.42% are rated C (Hold), 35.94% are rated D (Sell), and 20.3% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -199.97x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.